跳至主要内容
临床试验/NCT07427823
NCT07427823尚未招募不适用

Clinical Safety and Performance Evaluation of MUSA-3 in Microsurgical Anastomoses

Microsure0 个研究点目标入组 30 人开始时间: 2026年4月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
主要终点
Safety: device-related adverse events (AEs)

研究概览

简要总结

This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient age ≥ 18 years.
  • Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery.
  • Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU.
  • Able to give informed consent before participating in the study.
  • Provision of signed and dated informed consent form.

排除标准

  • Subject participates in a potentially confounding drug or device trial during the course of the study.
  • Patients that are pregnant or breastfeeding.
  • For Lymphedema patients:
  • ≥ISL (International Society of Lymphology) Stage III lymphedema
  • History of marcaine or indocyanine green allergy
  • Non-viable lymphatic system as determined by ICG lymphatic mapping using near infrared camera

研究组 & 干预措施

Robot-assisted anastomoses

Experimental

干预措施: Robot-assisted microsurgical anastomoses (Device)

结局指标

主要结局

Safety: device-related adverse events (AEs)

时间窗: Intraoperatively and through the 30-day post-procedure period

Performance: conversion rate to manual procedure

时间窗: Intraoperatively

Clinical performance: vessel patency rate

时间窗: Intraoperatively

次要结局

  • Anastomosis quality (SAMS score)(Intraoperatively)
  • Anastomosis time(Intraoperatively)

研究者

发起方
Microsure
申办方类型
Industry
责任方
Sponsor

相似试验